Predictive biomarker evaluation and molecular differentiation for imipridones ONC201 and ONC206.

被引：0
|
作者：
Morrow, Sara [1 ]
Nath, Kirti [1 ]
Zhang, Yiqun [2 ]
Garnett, Mathew J. [3 ]
McDermott, Ultan [3 ]
Benes, Cyril H. [4 ]
Basken, Joel [5 ]
El-Deiry, Wafik S. [2 ]
Allen, Joshua E. [1 ]
Prabhu, Varun V. [1 ]
机构：
[1] Oncoceut Inc, Philadelphia, PA USA
[2] Brown Univ, Providence, RI 02912 USA
[3] Wellcome Trust Sanger Inst, Hinxton, England
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Arpeggio Biosci, Boulder, CO USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer
    Wu, Laura Jinxuan
    Pinho-Schwermann, Maximilian
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Malpass, Ryan
    Seyhan, Attila A.
    Carneiro, Benedito A.
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12): : 6012 - 6036
  • [22] Anti-cancer efficacy of imipridones in pancreatic cancer: single agent ONC212 or combination of ONC201 with IGF1-R inhibition
    Lev, Avital
    Lulla, Amriti R.
    Wagner, Jessica
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2017, 77
  • [23] Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells
    Zhang, Yiqun
    Tapinos, Nikos
    Lulla, Rishi
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05):
  • [24] EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
    Arrillaga-Romany, Isabel
    Kurz, Sylvia
    Tarapore, Rohinton S.
    Sumrall, Ashley
    Butowski, Nicholas
    Harrison, Rebecca
    de Groot, John
    Chi, Andrew
    Shonka, Nicole
    Umemura, Yoshie
    Odia, Yazmin
    Mehta, Minesh
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Taylor, Lynne
    Graber, Jerome
    Kilburn, Lindsay
    Dixit, Karan
    Lu, Guangrong
    Allen, Joshua
    Batchelor, Tracy
    Lassman, Andrew
    Wen, Patrick
    NEURO-ONCOLOGY, 2020, 22 : 50 - 51
  • [25] Role of Dopamine Receptors in the Anticancer Activity of ONC201
    Kline, Christina Leah B.
    Ralff, Marie D.
    Lulla, Amriti R.
    Wagner, Jessica M.
    Abbosh, Phillip H.
    Dicker, David T.
    Allen, Joshua E.
    El-Deiry, Wafik S.
    NEOPLASIA, 2018, 20 (01): : 80 - 91
  • [26] Preclinical efficacy of new investigational drug ONC201 and analogs ONC212 and ONC206 against patient-derived pancreatic cancer cell lines.
    Lev, Avital
    Wagner, Jessica
    Lulla, Amriti R.
    Dicker, David T.
    El-Deiry, Wafik S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Imipridones ONC201 and ONC206 reduce expression of neogenin and EZH1/2 which correlate with synergy following their combination with EZH1/2 or HDAC inhibitors in treatment of DMG and other tumors
    Zhang, Yiqun
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [28] TRANSCRIPTOMIC AND PROTEOMIC ANALYSES OF DIPG RESPONSE TO ONC201
    Sridharan, Sreepradha
    Harmanci, Arif
    Sharma, Ajay
    Lai, Yanlai
    Kennis, Bridget
    Dobson, Tara
    Swaminathan, Jyothishmathi
    Haltom, Amanda
    Khatua, Soumen
    Tarapore, Rohinton
    Allen, Joshua
    Cheng, Donghang
    Zaky, Wafik
    Gopalakrishnan, Vidya
    NEURO-ONCOLOGY, 2020, 22 : 298 - 298
  • [29] Imipridone ONC201: combination therapy in hematologic malignancies
    Chari, Ajai
    Barlogie, Bart
    CELL CYCLE, 2018, 17 (16) : 1947 - 1948
  • [30] Targeting DRD2 dysregulation in recurrent glioblastoma with imipridone ONC201: predictive and pharmacodynamic clinical biomarker analyses
    Prabhu, Varun Vijay
    Madhukar, Neel
    Kline, C. Leah B.
    Tarapore, Rohinton
    El-Deiry, Wafik
    Elemento, Olivier
    Doherty, Faye
    VanEngelenburg, Alexander
    Durrant, Jessica
    Zloza, Andrew
    Benes, Cyril
    Arrillaga, Isabel
    Oster, Wolfgang
    Allen, Joshua E.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345